Clinical Trials Directory

Trials / Completed

CompletedNCT05052333

Examine the Psychosocial Impacts of COVID-19 Pandemic.

An International Study Examining the Psychosocial Impacts of COVID-19 Pandemic.

Status
Completed
Phase
Study type
Observational
Enrollment
2,574 (actual)
Sponsor
University of Otago · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is an observational study examining the psychosocial impacts of the COVID-19 pandemic in seven low-and-middle income countries (Indonesia, Iran, Iraq, Malaysia, Pakistan, Somaliland, and Turkiye). The data was obtained on standardised measures of wellbeing (WHO Well-Being Index), psychological distress (Kessler 10), post-traumatic stress (PTSD Checklist for DSM-5), post-traumatic growth (Posttraumatic Growth Inventory), and a novel pandemic-related stress (COVID Psychosocial Impacts Scale). Data was collected employing either a unilingual (in native language) or bilingual online survey (with English as a second language) from participants (N=2574) aged 18 and above using a non-probability convenient sampling. The findings enabled us to examine the psychosocial impacts of COVID-19, validate the translations of the CPIS and standardized measures; and determine the trajectory of study variables with pandemic exposure.

Conditions

Timeline

Start date
2021-12-01
Primary completion
2023-09-30
Completion
2023-10-31
First posted
2021-09-22
Last updated
2023-12-06

Locations

9 sites across 7 countries: United States, Indonesia, Iran, Iraq, Malaysia, Pakistan, Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05052333. Inclusion in this directory is not an endorsement.